Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Albireo Pharma Inc (NASDAQ:ALBO)

22.24
Delayed Data
As of Sep 22
 +0.08 / +0.36%
Today’s Change
12.30
Today|||52-Week Range
37.69
+25.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues0.000.001.0K1.0K
 
 
 
Depreciation And Amortization50.0K1.0K5.0K8.0K
 
 
 
 
 
 
Operating ExpensesGross Income-50.0K-1.0K----
 
 
 
General Expenses6.0M3.1M6.0M6.7M
 
 
 
 
 
Other Operating Expenses0.000.0074.0K-65.0K
 
 
 
Research And Development2.1M64.0K2.8M3.0M
 
 
 
 
 
Total Operating Expenses6.1M3.1M6.1M6.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.1M-3.1M-6.1M-6.6M
 
 
 
 
 
Extraordinary Credit--0.000.00609.0K
 
 
Extraordinary Charge-3.0K-4.0K0.000.00
 
 
 
Interest Expense On Debt0.000.00249.0K152.0K
 
 
 
Other Expenses0.000.00-325.0K-24.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.9M-3.1M-6.7M-6.2M
 
 
 
 
 
Income Taxes-8.0K-3.0K0.000.00
 
 
 
Net Income-5.9M-3.1M-6.7M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.1M2.1M6.3M7.2M
 
 
 
 
 
Shares To Calculate EPS Diluted2.1M2.1M6.3M7.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.70-$1.50-$1.06-$0.86
 
 
 
 
 
EPS Diluted-$2.70-$1.50-$1.06-$0.86